Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers

Clinical Validation of an Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Indicating Cognitive Decline

This study aims to provide clinical validation of EyeQuant, a fully automated retinal image analysis system for computation of vascular biomarkers indicative of cognitive disorders, using retinal fundus photographs collected from patients with mild cognitive impairment, Alzheimer's disease, and vascular dementia.

Inclusion Criteria:

- Patients older than 18 years and diagnosed with mild cognitive impairment (MCI), Alzheimer's disease (AD), or vascular cognitive impairment and/or dementia (VaD).

Exclusion Criteria:

• Children and subjects with other diagnoses than those mentioned in the inclusion criteria.
• Patients without the means to visit the clinic on the assigned dates.
• Patients who are pregnant or are expecting to become pregnant.